NOS2 (iNOS) deficiency in kidney donor accelerates allograft loss in a murine model

American Journal of Transplantation

Volumn 7, Issue 1, 2007, Pages 17-26

  Du, C ^a,c   Jiang, J ^a   Guan, Q ^c   Diao, H ^a   Yin, Z ^c   Wang, S ^a   Zhong, R ^a,b,c   Jevnikar, A M ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Apoptosis; Epithelium; Kidney; Nitric oxide; NOS2; Transplantation; Tubular

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME SYNTHESIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; IN VITRO STUDY; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NITRIC OXIDE SYNTHASE 2 DEFICIENCY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES COMPARISON; SURVIVAL RATE; SURVIVAL TIME; WILD TYPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL PROLIFERATION; GRAFT REJECTION; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33845656930     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01558.x     Document Type: Article

References (56)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
3. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
4. McLay JS, Chatterjee P, Nicolson AG et al. Nitric oxide production by human proximal tubular cells: A novel immunomodulatory mechanism? Kidney Int 1994; 46: 1043-1049.
5. Guzman NJ, Fang MZ, Tang SS, Ingelfinger JR, Garg LC. Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 1995; 95: 2083-2088.
6. Poljakovic M, Karpman D, Svanborg C, Persson K. Human renal epithelial cells express iNOS in response to cytokines but not bacteria. Kidney Int 2002; 61: 444-455.
7. Du C, Guan Q, Diao H, Yin Z, Jevnikar AM. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol 2006; 290: F1044-F1054.
8. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci USA 1994; 91: 5387-5391.
9. Kroncke KD, Fehsel K, Suschek C, Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 2001; 1: 1407-1420.
10. Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 2002; 35: 116-126.
11. Fiorucci S, Distrutti E, Ajuebor MN et al. NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 2001; 281: G654-G665.
12. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402-1411.
13. Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Gastroenterology 2001; 120: 1251-1262.
14. Migita K, Yamasaki S, Kita M et al. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3. Immunology 2001; 103: 362-367.
15. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080-5085.
16. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994; 213: 172-177.
17. Glynne PA, Evans TJ. Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers. Kidney Int 1999; 55: 2573-2597.
18. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. Murine renal allografts: Spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 2001; 167: 4821-4827.
19. Coffman T, Geier S, Ibrahim S et al. Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol 1993; 151: 425-435.
20. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. The graft helps to define the character of the alloimmune response. Transpl Immunol 2002; 9: 137-141.
21. Frasca L, Marelli-Berg F, Imami N et al. Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 1998; 53: 678-689.
22. Klahr S, Morrissey J. Renal disease: The two faces of nitric oxide. Lab Invest 1995; 72: 1-3.
23. Mattson DL, Wu F. Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension 2000; 35: 337-341.
24. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 1993; 91: 2138-2143.
25. Romagnani P, Pupilli C, Lasagni L et al. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol 1999; 187: 345-350.
26. Vos IH, Joles JA, Schurink M et al. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection. Eur J Pharmacol 2000; 391: 31-38.
27. Chatterjee PK, Patel NS, Kvale EO et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002; 61: 862-871.
28. Chatterjee PK, Patel NSA, Sivarajah A et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 2003; 63: 853-865.
29. Noiri E, Nakao A, Uchida K et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001; 281: F948-F957.
30. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: Studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine. J Pharmacol Exp Ther 2000; 295: 417-422.
31. Ling H, Edelstein C, Gengaro P et al. Attenuation of renal ischemiareperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 1999; 277: F383-F390.
32. Du C, Jiang J, Guan Q et al. Renal tubular epithelial cell self-injury through Fas/Fas ligand interaction promotes renal allograft injury. Am J Transplant 2004; 4: 1583-1594.
33. van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1: 1491-1500.
34. Jevnikar AM, Brennan DC, Singer GG et al. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 1991; 40: 203-211.
35. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophage. Proc Natl Acad Sci USA 1997; 94: 6954-6958.
36. Rubin-Kelley VE, Jevnikar AM. Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 1991; 2: 13-26.
37. Mohaupt MG, Schwobel J, Elzie JL, Kannan GS, Kone BC. Cytokines activate inducible nitric oxide synthase gene transcription in inner medullary collecting duct cells. Am J Physiol 1995; 268: F770-777.
38. Smith SD, Wheeler MA, Zhang R et al. Nitric oxide synthase induction with renal transplant rejection or infection. Kidney Int 1996; 50: 2088-2093.
39. Floege J, Grone HJ. Progression of renal failure: What is the role of cytokines? Nephrol Dial Transplant 1995; 10: 1575-1586.
40. Gabbai FB, Boggiano C, Peter T et al. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997; 159: 6266-6275.
41. Cattell V, Smith J, Jansen A, Riveros-Moreno V, Moncada S. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat. Transplantation 1994; 58: 1399-1402.
42. Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003; 76: 1015-1022.
43. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97: 2377-2383.
44. Stojanovic T, Grone HJ, Gieseler RK et al. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: A nonimmunologic influence on alloreactivity. Lab Invest 1996; 74: 496-512.
45. Reilly CM, Farrelly LW, Viti D et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 2002; 61: 839-846.
46. Gilkeson GS, Mudgett JS, Seldin MF et al. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 1997; 186: 365-373.
47. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: Insights from NOS2-knockout mice. Am J Pathol 1998; 153: 1371-1376.
48. Miyajima A, Chen J, Poppas DP, Vaughan Jr ED, Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 2001; 59: 1290-1303.
49. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
50. Sandau K, Pfeilschifter J, Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 1997; 52: 378-386.
51. Blesson S, Thiery J, Gaudin C et al. Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. Int Immunol 2002; 14: 1169-1178.
52. Daniel T, Alexander M, Hubbard WJ, Chaudry IH, Choudhry MA, Schwacha MG. Nitric oxide contributes to the development of a post-injury Th2 T-cell phenotype and immune dysfunction. J Cell Physiol 2006; 208: 418-427.
53. Dedeoglu IO, Feld LG. Decreased urinary excretion of nitric oxide in acute rejection episodes in pediatric renal allograft recipients. Transplantation 1996; 62: 1936-1938.
54. Albrecht EW, van Goor H, Tiebosch AT, Moshage H, Tegzess AM, Stegeman CA. Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection. Transplantation 2000; 70: 1610-1616.
55. Romagnani P, Pupilli C, Lasagni L et al. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol 1999; 187: 345-350.
56. Kaizu T, Ikeda A, Nakao A et al. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 2006; 43: 464-473.